Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 24Prostatic Neoplasms 16Sarcoma 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 5Uterine Cervical Neoplasms 4Endometrial Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Liposarcoma, Myxoid 3Head and Neck Neoplasms 3Glioblastoma 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Synovial 2Radiation Injuries 2Pancreatic Neoplasms 2Neurofibrosarcoma 2Neoplasms 2Melanoma 2Lymphatic Metastasis 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Fibrosarcoma 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Advanced Refractory Solid Tumors 2Uterine Neoplasms 1Urothelial Cancer 1Urogenital Neoplasms 1

Interventions

lentiviral minigene vaccine of COVID-19 coronavirus 1Radiation Dose Hypofractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Myosarcoma × Radiation Dose Hypofractionation × Clear all
NCT03651375 2021-01-22

UN-RESARC

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Unknown
46 enrolled
Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Lymphangiosarcoma, Myosarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Histiocytic Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡